Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Rheumatoid Arthritis: HELP
Vibeke Strand
Based on 61 articles published since 2009
(Why 61 articles?)
||||
Expertise Level
The expertise of Vibeke Strand ranks in the
  • Top 0.072%
  • ... of 82,356 published authors worldwide on Rheumatoid Arthritis
  • ... from 2009 through 2019
  • ... based on contributions to 61 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Strand, Vibeke   ·   Strand, V
Work Locations
Details
Most likely:    Stanford University   Contact    
2018
  • Stanford University, Palo Alto, CA, USA. · Sorbonne Universités, UPMC Université Paris 6, GRC-UPMC 08 (EEMOIS), Paris, France. · Department of Rheumatology, Assistance publique - Hôpitaux de Paris, Pitié Salpêtrière Hospital, Paris, France. · Sanofi, Guildford, UK. · Present Address: ViiV Healthcare, Brentford, UK. · Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591-6707, USA. · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591-6707, USA. · Present Address: Celgene, Summit, NJ, USA. · Sanofi, Bridgewater, NJ, USA. · Charité - University Medicine, Berlin, Germany. · Pubmed 29921318
  • Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA. · Seoul National University, Seoul, Republic of Korea. · Hospital of Joint Diseases, New York University, New York, NY, USA. · Cabrillo Center for Rheumatic Disease, San Diego, CA, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Inc, Collegeville, PA, USA. · Drexel University College of Medicine, Philadelphia, PA, USA. · Pubmed 29656373
  • Department of Rheumatology, Amsterdam Rheumatology and Immunology Center ARC, Amsterdam, The Netherlands. · The Rebecca MacDonald Centre For Arthritis, Mount Sinai Hospital, Toronto, Ontario, Canada. · Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA. · Investigacion y Biomedicina de Chihuahua, Chihuahua, Mexico. · Institute of Rheumatology, Prague, Czech Republic. · Center for Innovative Diagnostics and Therapy in Rheumatology/Immunology (CIRI), Goethe University Frankfurt, Frankfurt, Germany. · ZDROWIE Osteo-Medic, Bialystok, Poland. · Biotest AG, Dreieich, Germany. · Pubmed 29343509
  • 1 Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California. · 2 AbbVie, North Chicago, Illinois. · 3 Analysis Group, Boston, Massachusetts. · Pubmed 29578852
2017
  • University of California, Los Angeles, California, David Geffen School of Medicine, Los Angeles, California, USA. · Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA. · Pubmed 27689734
  • Division of Immunology/Rheumatology, Stanford University School of Medicine, 306 Ramona Road, Portola Valley, CA, 94028, USA. · Rheumatology Unit, Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid, Spain. · Rheumatology Section, Dubai Hospital, Dubai, United Arab Emirates. · Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico. · Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan. · Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. · Market Access Solutions, Envision Pharma Group, London, UK. · Pfizer Ltd, Surrey, UK. · Medical Affairs, Pfizer, Collegeville, PA, USA. · Pubmed 28612180
  • Stanford University School of Medicine, Palo Alto, California. · Albany Medical College, Albany, New York. · Pfizer Inc, Groton, Connecticut. · Pubmed 27565000
  • a Precision Health Economics , Oakland , CA , USA. · b Amgen Inc. , Thousand Oaks , CA , USA. · c Division of Immunology/Rheumatology , Stanford University , Palo Alto , CA , USA. · Pubmed 28294642
  • Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, University of Munich, Munich, Germany. · Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA. · US Medical Affairs, Pfizer Inc, Collegeville, PA · Pfizer Innovative Health, Inflammation & Immunology, Global Medical Affairs, Pfizer Inc, New York, NY. · Global Health Value, Pfizer Inc, Groton, CT. · Global Product Development, Pfizer Inc, New York, NY, USA. · Clinical Development, Pfizer Inc, Groton, CT, USA. · Pubmed 28028154
  • Spire Sciences, Inc., Boca Raton, Florida, USA. · Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA. · Department of Biomedical Data Science, Stanford University, Palo Alto, California, USA. · Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup, Denmark. · Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. · Division of Arthritis & Rheumatic Diseases (OPO9), Oregon Health & Science University, Portland, Oregon, USA. · Amsterdam Rheumatology & Immunology Center (ARC)(AMC), Amsterdam, The Netherlands. · Zuyderland Medical Center, Heerlen, The Netherlands. · Division of Rheumatology, University of California, Los Angeles, California, USA. · David Geffen School of Medicine, Los Angeles, California, USA. · The Doctors of Saint John's Medical Group, Providence Saint John's Health Center, Santa Monica, California, USA. · Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK. · NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK. · Pubmed 27974302
  • University of Alabama at Birmingham. · New York University Langone Medical Center, New York, NY. · Stanford University School of Medicine, Stanford, CA. · CSD Biostatistics, Inc., Oro Valley, AZ. · Crescendo Bioscience, South San Francisco, CA. · Pubmed 27813312
2016
  • Stanford University Medical Center, Palo Alto, CA, USA. · Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, 94303, USA. · , Mailing address: 306 Ramona Road, Portola Valley, California, 94028, USA. · Optum, Lincoln, RI, USA. · Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA. · Sanofi Genzyme, Bridgewater, NJ, USA. · now with Novartis, East Hanover, NJ, USA. · Leiden University Medical Centre, Leiden, The Netherlands. · Stanford University Medical Center, Palo Alto, CA, USA. · Pubmed 27600829
  • Division of Rheumatology, Medical University of Vienna and Hietzing Hospital, Vienna, Austria. · Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA. · Pfizer, Collegeville, PA, USA. · inVentiv Health, Princeton, NJ, USA. · Pfizer, New York, NY, USA. · Pubmed 27209012
  • Duke University School of Medicine, Durham, NC, USA. · Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA. · The NIHR Newcastle Biomedical Research Centre, Newcastle University and Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. · Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. · Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA. · Dermatology Centre, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. · Hospital General de Cuernavaca, Cuernavaca, Morelos, Mexico. · Pfizer Inc, 500 Arcola Rd, Collegeville, PA, 19426, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, New York, NY, USA. · Pfizer Inc, 500 Arcola Rd, Collegeville, PA, 19426, USA. · Pubmed 27282428
  • Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Groton, CT, USA. · Metroplex Clinical Research Center, Dallas, TX, USA. · University of Genoa, Italy. · Stanford University, Stanford, CA, USA. · Hospital Clinico Universitario, Santiago de Compostela, Spain. · Albany Medical College, Albany, NY, USA. · Seoul National University College of Medicine, Seoul, Republic of Korea. · Instituto Nacional de Ciencias Médicas y Nutrición-Salvador Zubirán, Mexico City, Mexico. · Pubmed 27156561
  • Stanford University, Palo Alto, California. · New York University School of Medicine, New York, and CORRONA, Southborough, Massachusetts. · AbbVie, North Chicago, Illinois. · CORRONA, Southborough, Massachusetts. · Axio Research, Seattle, Washington. · Pubmed 26555655
2015
  • Biopharmaceutical Consultant, 306 Ramona Road, Portola Valley, CA, 94028, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Metrum Research Group, 2 Tunxis Rd Ste 112, Tariffville, CT, 06081, USA. · Pfizer Inc, 235 East 42nd Street, New York, NY, 10017, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Complejo Hospitalario Universitario de Santiago de Compostela, Travesía de Choupana, s/n, 15706, Santiago de Compostela, Spain. · Pubmed 26669566
  • Biopharmaceutical Consultant, Portola Valley, CA, USA. · Stanford University, Palo Alto, CA, USA. · Center for Rheumatology, Albany Medical College, Albany, NY, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Metroplex Clinical Research Center, Dallas, TX, USA. · Pubmed 26530039
  • From Division of Immunology/Rheumatology, Stanford University School of Medicine, Stanford, CA; New York University Langone Medical Center, New York, NY; Drexel University College of Medicine, Philadelphia, PA; UCB Pharma, Smyrna, GA, USA; Kennedy Institute of Rheumatology, Oxford, UK.V. Strand, MD, FACP, FACR, Biopharmaceutical Consultant; Adjunct Professor, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.C. Wright, MD, New York University Langone Medical Center; M.J. Bergman, MD, Drexel University College of Medicine; J. Tambiah, MD, UCB Pharma; P.C. Taylor, MD, Kennedy Institute of Rheumatology. · Pubmed 26233504
  • University of Nebraska Medical Center, Omaha, NE, National Data Bank for Rheumatic Diseases, Wichita, KS. · Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA. · Brigham & Women's Hospital, Division of Rheumatology, Immunology and Allergy, Boston, MA. · Cedar Associates, Menlo Park, CA. · Crescendo Bioscience, San Francisco, CA, USA and. · Cedar Associates, Menlo Park, CA, Department of Internal Medicine, Stanford University School of Medicine, Palo Alto, CA, USA · Pubmed 25877911
2014
  • Divisions of Rheumatology, University of Toronto, Toronto, Ontario, Canada. · Respirology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California. · Johns Hopkins University School of Medicine, Baltimore, Maryland. · Northern Ontario School of Medicine, Greater Sudbury, Ontario, Canada. · Divisions of Rheumatology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 24630861
  • University of Toronto, Toronto, Canada. · Academic Medical Center Amsterdam & Atrium Medical Center, Heerlen, The Netherlands. · Karolinska Institute, Stockholm, Sweden. · Montpellier University Hospital, Montpellier, France. · Stanford University, Palo Alto, California, USA. · Swedish Medical Center and University of Washington, Seattle, Washington, USA. · UCB Pharma, Raleigh, North Carolina, USA. · Leiden University Medical Center, Leiden, The Netherlands. · Pubmed 23918037
2012
  • Division of Immunology, Stanford University, 306 Ramona Road, Portola Valley, CA 94028, USA. · Pubmed 22753773
  • Division of Immunology/Rheumatology, Stanford University School of Medicine, 306 Ramona Road, Portola Valley, CA 94028, USA. · Pubmed 22045836
  • Division of Immunology/Rheumatology, Stanford University, 306 Ramona Road, Portola Valley, CA 94028, USA. · Pubmed 22258482
2011
  • Division of Immunology/Rheumatology, Stanford University School of Medicine, Portola Valley, CA, USA. · Pubmed 21885508
  • Division of Immunology and Rheumatology, Stanford University, 306 Ramona Road, Portola Valley, CA 94028, USA. · Pubmed 21415050
  • Department of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA. · Pubmed 21807792
2010
  • Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA. · Pubmed 20576223
  • Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California 94305, USA. · Pubmed 20108988
2009
  • Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, 1000 Welch Road, Suite 203, Palo Alto, CA 94304, USA. · Pubmed 19232061
  • Division of Immunology/Rheumatology, Stanford University School of Medicine, 306 Ramona Road, Palo Alto, CA, 94028, USA. · Pubmed 19909548
  • Division of Immunology/Rheumatology, Stanford University School of Medicine, Stanford, California, USA. · Pubmed 19910301
2017
  • From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Advisory Services, Quintiles IMS; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Instituto de Salud Musculoesqueletica, Madrid, Spain. · N.V. Zamora, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; N. Goel, MD, PhD, Advisory Services, Quintiles IMS, and Division of Rheumatology, Duke University School of Medicine; L. Klokker, PT, MSc, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L.E. Kristensen, MD, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; V. Strand, MD, MACR, FACP, Division of Immunology and Rheumatology, Stanford University; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center. · From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Advisory Services, Quintiles IMS; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Instituto de Salud Musculoesqueletica, Madrid, Spain. · N.V. Zamora, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; N. Goel, MD, PhD, Advisory Services, Quintiles IMS, and Division of Rheumatology, Duke University School of Medicine; L. Klokker, PT, MSc, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L.E. Kristensen, MD, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; V. Strand, MD, MACR, FACP, Division of Immunology and Rheumatology, Stanford University; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center. · Pubmed 28620065
2016
  • From the Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute at Barts, and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Rheumatology and Translational Immunology Research Laboratories (LaRIT), Division of Rheumatology, IRCCS Policlinico San Matteo Foundation/University of Pavia, Pavia, Italy; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, and Rheumatology Department, Lisbon Academic Medical Centre, Lisbon, Portugal; Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; Rheumatology Department, Ambroise Paré Hospital, APHP, Université Versailles Saint Quentin en Yvelines, Inserm U987, Boulogne-Billancourt, France; Rheumatology Department, Hospital Universitario Severo Ochoa, Madrid, Spain; Laboratory for Skeletal Development and Joint Disorders, Department of Development and Regeneration, KU Leuven, Leuven, Belgium; University of Cambridge, Cambridge, UK; GlaxoSmithKline Research and Development, Stevenage, UK; School of Medicine and Medical Science, St. Vincent's University Hospital, Dublin, Ireland; Rheumatology Research Unit, Repatriation General Hospital, Daw Park, South Australia; Dublin Academic Medical Centre, The Conway Institute of Biomedical and Biomolecular Research, University College Dublin, Dublin, Ireland; Cardiff Institute of Infection and Immunity, Cardiff Regional Experimental Arthritis Treatment and Evaluation Centre, Cardiff, UK; Division of Immunology/Rheumatology, Stanford University School of Medicine, Stanford, California, USA.F. Humby, MRCP; S. Kelly, MRCP, Centre for Experimental Medicine and Rheumatology, William Harvey Research Ins · Pubmed 26034155
2011
  • Division of Immunology and Rheumatology,Stanford University, 1000 Welch Road #203, Palo Alto, CA 94304, USA. · Pubmed 21285160
2010
  • Division of Rheumatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA. · Pubmed 20969557
  • Stanford University, Palo Alto, CA, USA. · Pubmed 20448284
Probable:    Miscellaneous cities in California      
2016
  • Private residence, CA, USA. · Department of Medicine, Karolinska Institute, Stockholm, Sweden. · Department of Internal Medicine, Seoul National University, Seoul, Republic of Korea. · Rheumatology Department, Metroplex Clinical Research Center, Dallas, TX. · Medicines Development Group, Pfizer Inc, Groton, CT and. · Medicines Development Group, Pfizer Inc, New York, NY, USA. · Medicines Development Group, Pfizer Inc, Groton, CT and · Pubmed 26929445
Probable:    New York University   Contact    
2015
  • From Division of Immunology/Rheumatology, Stanford University School of Medicine, Stanford, CA; New York University Langone Medical Center, New York, NY; Drexel University College of Medicine, Philadelphia, PA; UCB Pharma, Smyrna, GA, USA; Kennedy Institute of Rheumatology, Oxford, UK.V. Strand, MD, FACP, FACR, Biopharmaceutical Consultant; Adjunct Professor, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.C. Wright, MD, New York University Langone Medical Center; M.J. Bergman, MD, Drexel University College of Medicine; J. Tambiah, MD, UCB Pharma; P.C. Taylor, MD, Kennedy Institute of Rheumatology. · Pubmed 26233504
2009
  • Department of Rheumatology, New York University Hospital for Joint Diseases, New York, NY 10003, USA. · Pubmed 19395544
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 61 total) written by Vibeke Strand about Rheumatoid Arthritis:

  • Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis. 2018
  • Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials. 2018
  • Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial. 2018
  • Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid Arthritis. 2018
  • Importance of 'meeting of the minds': patient-reported outcomes and MRI. 2017
  • Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review. 2017
  • Tofacitinib in Combination With Conventional Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient-Reported Outcomes From a Phase III Randomized Controlled Trial. 2017
  • Critical Outcomes in Longitudinal Observational Studies and Registries in Patients with Rheumatoid Arthritis: An OMERACT Special Interest Group Report. 2017
  • Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators. 2017
  • Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studies. 2017
Show List of Full Article Records
Google Searches

Learn more about Vibeke Strand using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Stanford University
Miscellaneous cities in California
New York University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Stanford University
2018
  • Stanford University, Palo Alto, CA, USA. · Sorbonne Universités, UPMC Université Paris 6, GRC-UPMC 08 (EEMOIS), Paris, France. · Department of Rheumatology, Assistance publique - Hôpitaux de Paris, Pitié Salpêtrière Hospital, Paris, France. · Sanofi, Guildford, UK. · Present Address: ViiV Healthcare, Brentford, UK. · Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591-6707, USA. · Sanofi, Paris, France. · Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY, 10591-6707, USA. · Present Address: Celgene, Summit, NJ, USA. · Sanofi, Bridgewater, NJ, USA. · Charité - University Medicine, Berlin, Germany. · Pubmed 29921318
  • Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA. · Seoul National University, Seoul, Republic of Korea. · Hospital of Joint Diseases, New York University, New York, NY, USA. · Cabrillo Center for Rheumatic Disease, San Diego, CA, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Inc, Collegeville, PA, USA. · Drexel University College of Medicine, Philadelphia, PA, USA. · Pubmed 29656373
  • Department of Rheumatology, Amsterdam Rheumatology and Immunology Center ARC, Amsterdam, The Netherlands. · The Rebecca MacDonald Centre For Arthritis, Mount Sinai Hospital, Toronto, Ontario, Canada. · Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA. · Investigacion y Biomedicina de Chihuahua, Chihuahua, Mexico. · Institute of Rheumatology, Prague, Czech Republic. · Center for Innovative Diagnostics and Therapy in Rheumatology/Immunology (CIRI), Goethe University Frankfurt, Frankfurt, Germany. · ZDROWIE Osteo-Medic, Bialystok, Poland. · Biotest AG, Dreieich, Germany. · Pubmed 29343509
  • 1 Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California. · 2 AbbVie, North Chicago, Illinois. · 3 Analysis Group, Boston, Massachusetts. · Pubmed 29578852
2017
  • University of California, Los Angeles, California, David Geffen School of Medicine, Los Angeles, California, USA. · Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA. · Pubmed 27689734
  • Division of Immunology/Rheumatology, Stanford University School of Medicine, 306 Ramona Road, Portola Valley, CA, 94028, USA. · Rheumatology Unit, Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid, Spain. · Rheumatology Section, Dubai Hospital, Dubai, United Arab Emirates. · Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico. · Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan. · Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. · Market Access Solutions, Envision Pharma Group, London, UK. · Pfizer Ltd, Surrey, UK. · Medical Affairs, Pfizer, Collegeville, PA, USA. · Pubmed 28612180
  • Stanford University School of Medicine, Palo Alto, California. · Albany Medical College, Albany, New York. · Pfizer Inc, Groton, Connecticut. · Pubmed 27565000
  • a Precision Health Economics , Oakland , CA , USA. · b Amgen Inc. , Thousand Oaks , CA , USA. · c Division of Immunology/Rheumatology , Stanford University , Palo Alto , CA , USA. · Pubmed 28294642
  • Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, University of Munich, Munich, Germany. · Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA. · US Medical Affairs, Pfizer Inc, Collegeville, PA · Pfizer Innovative Health, Inflammation & Immunology, Global Medical Affairs, Pfizer Inc, New York, NY. · Global Health Value, Pfizer Inc, Groton, CT. · Global Product Development, Pfizer Inc, New York, NY, USA. · Clinical Development, Pfizer Inc, Groton, CT, USA. · Pubmed 28028154
  • Spire Sciences, Inc., Boca Raton, Florida, USA. · Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA. · Department of Biomedical Data Science, Stanford University, Palo Alto, California, USA. · Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup, Denmark. · Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. · Division of Arthritis & Rheumatic Diseases (OPO9), Oregon Health & Science University, Portland, Oregon, USA. · Amsterdam Rheumatology & Immunology Center (ARC)(AMC), Amsterdam, The Netherlands. · Zuyderland Medical Center, Heerlen, The Netherlands. · Division of Rheumatology, University of California, Los Angeles, California, USA. · David Geffen School of Medicine, Los Angeles, California, USA. · The Doctors of Saint John's Medical Group, Providence Saint John's Health Center, Santa Monica, California, USA. · Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK. · NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK. · Pubmed 27974302
  • University of Alabama at Birmingham. · New York University Langone Medical Center, New York, NY. · Stanford University School of Medicine, Stanford, CA. · CSD Biostatistics, Inc., Oro Valley, AZ. · Crescendo Bioscience, South San Francisco, CA. · Pubmed 27813312
2016
  • Stanford University Medical Center, Palo Alto, CA, USA. · Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, 94303, USA. · , Mailing address: 306 Ramona Road, Portola Valley, California, 94028, USA. · Optum, Lincoln, RI, USA. · Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA. · Sanofi Genzyme, Bridgewater, NJ, USA. · now with Novartis, East Hanover, NJ, USA. · Leiden University Medical Centre, Leiden, The Netherlands. · Stanford University Medical Center, Palo Alto, CA, USA. · Pubmed 27600829
  • Division of Rheumatology, Medical University of Vienna and Hietzing Hospital, Vienna, Austria. · Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA. · Pfizer, Collegeville, PA, USA. · inVentiv Health, Princeton, NJ, USA. · Pfizer, New York, NY, USA. · Pubmed 27209012
  • Duke University School of Medicine, Durham, NC, USA. · Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA. · The NIHR Newcastle Biomedical Research Centre, Newcastle University and Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. · Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. · Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA. · Dermatology Centre, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. · Hospital General de Cuernavaca, Cuernavaca, Morelos, Mexico. · Pfizer Inc, 500 Arcola Rd, Collegeville, PA, 19426, USA. · Pfizer Inc, Groton, CT, USA. · Pfizer Inc, New York, NY, USA. · Pfizer Inc, 500 Arcola Rd, Collegeville, PA, 19426, USA. · Pubmed 27282428
  • Pfizer Inc, Groton, CT, USA. · Pfizer Inc, Groton, CT, USA. · Metroplex Clinical Research Center, Dallas, TX, USA. · University of Genoa, Italy. · Stanford University, Stanford, CA, USA. · Hospital Clinico Universitario, Santiago de Compostela, Spain. · Albany Medical College, Albany, NY, USA. · Seoul National University College of Medicine, Seoul, Republic of Korea. · Instituto Nacional de Ciencias Médicas y Nutrición-Salvador Zubirán, Mexico City, Mexico. · Pubmed 27156561
  • Stanford University, Palo Alto, California. · New York University School of Medicine, New York, and CORRONA, Southborough, Massachusetts. · AbbVie, North Chicago, Illinois. · CORRONA, Southborough, Massachusetts. · Axio Research, Seattle, Washington. · Pubmed 26555655
2015
  • Biopharmaceutical Consultant, 306 Ramona Road, Portola Valley, CA, 94028, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Metrum Research Group, 2 Tunxis Rd Ste 112, Tariffville, CT, 06081, USA. · Pfizer Inc, 235 East 42nd Street, New York, NY, 10017, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Pfizer Inc, Eastern Point Road, Groton, CT, 06340, USA. · Complejo Hospitalario Universitario de Santiago de Compostela, Travesía de Choupana, s/n, 15706, Santiago de Compostela, Spain. · Pubmed 26669566
  • Biopharmaceutical Consultant, Portola Valley, CA, USA. · Stanford University, Palo Alto, CA, USA. · Center for Rheumatology, Albany Medical College, Albany, NY, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Metroplex Clinical Research Center, Dallas, TX, USA. · Pubmed 26530039
  • From Division of Immunology/Rheumatology, Stanford University School of Medicine, Stanford, CA; New York University Langone Medical Center, New York, NY; Drexel University College of Medicine, Philadelphia, PA; UCB Pharma, Smyrna, GA, USA; Kennedy Institute of Rheumatology, Oxford, UK.V. Strand, MD, FACP, FACR, Biopharmaceutical Consultant; Adjunct Professor, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.C. Wright, MD, New York University Langone Medical Center; M.J. Bergman, MD, Drexel University College of Medicine; J. Tambiah, MD, UCB Pharma; P.C. Taylor, MD, Kennedy Institute of Rheumatology. · Pubmed 26233504
  • University of Nebraska Medical Center, Omaha, NE, National Data Bank for Rheumatic Diseases, Wichita, KS. · Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA. · Brigham & Women's Hospital, Division of Rheumatology, Immunology and Allergy, Boston, MA. · Cedar Associates, Menlo Park, CA. · Crescendo Bioscience, San Francisco, CA, USA and. · Cedar Associates, Menlo Park, CA, Department of Internal Medicine, Stanford University School of Medicine, Palo Alto, CA, USA · Pubmed 25877911
2014
  • Divisions of Rheumatology, University of Toronto, Toronto, Ontario, Canada. · Respirology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California. · Johns Hopkins University School of Medicine, Baltimore, Maryland. · Northern Ontario School of Medicine, Greater Sudbury, Ontario, Canada. · Divisions of Rheumatology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 24630861
  • University of Toronto, Toronto, Canada. · Academic Medical Center Amsterdam & Atrium Medical Center, Heerlen, The Netherlands. · Karolinska Institute, Stockholm, Sweden. · Montpellier University Hospital, Montpellier, France. · Stanford University, Palo Alto, California, USA. · Swedish Medical Center and University of Washington, Seattle, Washington, USA. · UCB Pharma, Raleigh, North Carolina, USA. · Leiden University Medical Center, Leiden, The Netherlands. · Pubmed 23918037
2012
  • Division of Immunology, Stanford University, 306 Ramona Road, Portola Valley, CA 94028, USA. · Pubmed 22753773
  • Division of Immunology/Rheumatology, Stanford University School of Medicine, 306 Ramona Road, Portola Valley, CA 94028, USA. · Pubmed 22045836
  • Division of Immunology/Rheumatology, Stanford University, 306 Ramona Road, Portola Valley, CA 94028, USA. · Pubmed 22258482
2011
  • Division of Immunology/Rheumatology, Stanford University School of Medicine, Portola Valley, CA, USA. · Pubmed 21885508
  • Division of Immunology and Rheumatology, Stanford University, 306 Ramona Road, Portola Valley, CA 94028, USA. · Pubmed 21415050
  • Department of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA. · Pubmed 21807792
2010
  • Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA. · Pubmed 20576223
  • Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California 94305, USA. · Pubmed 20108988
2009
  • Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, 1000 Welch Road, Suite 203, Palo Alto, CA 94304, USA. · Pubmed 19232061
  • Division of Immunology/Rheumatology, Stanford University School of Medicine, 306 Ramona Road, Palo Alto, CA, 94028, USA. · Pubmed 19909548
  • Division of Immunology/Rheumatology, Stanford University School of Medicine, Stanford, California, USA. · Pubmed 19910301
2017
  • From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Advisory Services, Quintiles IMS; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Instituto de Salud Musculoesqueletica, Madrid, Spain. · N.V. Zamora, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; N. Goel, MD, PhD, Advisory Services, Quintiles IMS, and Division of Rheumatology, Duke University School of Medicine; L. Klokker, PT, MSc, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L.E. Kristensen, MD, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; V. Strand, MD, MACR, FACP, Division of Immunology and Rheumatology, Stanford University; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center. · From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Advisory Services, Quintiles IMS; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Instituto de Salud Musculoesqueletica, Madrid, Spain. · N.V. Zamora, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; N. Goel, MD, PhD, Advisory Services, Quintiles IMS, and Division of Rheumatology, Duke University School of Medicine; L. Klokker, PT, MSc, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L.E. Kristensen, MD, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; V. Strand, MD, MACR, FACP, Division of Immunology and Rheumatology, Stanford University; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center. · Pubmed 28620065
2016
  • From the Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute at Barts, and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Rheumatology and Translational Immunology Research Laboratories (LaRIT), Division of Rheumatology, IRCCS Policlinico San Matteo Foundation/University of Pavia, Pavia, Italy; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, and Rheumatology Department, Lisbon Academic Medical Centre, Lisbon, Portugal; Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; Rheumatology Department, Ambroise Paré Hospital, APHP, Université Versailles Saint Quentin en Yvelines, Inserm U987, Boulogne-Billancourt, France; Rheumatology Department, Hospital Universitario Severo Ochoa, Madrid, Spain; Laboratory for Skeletal Development and Joint Disorders, Department of Development and Regeneration, KU Leuven, Leuven, Belgium; University of Cambridge, Cambridge, UK; GlaxoSmithKline Research and Development, Stevenage, UK; School of Medicine and Medical Science, St. Vincent's University Hospital, Dublin, Ireland; Rheumatology Research Unit, Repatriation General Hospital, Daw Park, South Australia; Dublin Academic Medical Centre, The Conway Institute of Biomedical and Biomolecular Research, University College Dublin, Dublin, Ireland; Cardiff Institute of Infection and Immunity, Cardiff Regional Experimental Arthritis Treatment and Evaluation Centre, Cardiff, UK; Division of Immunology/Rheumatology, Stanford University School of Medicine, Stanford, California, USA.F. Humby, MRCP; S. Kelly, MRCP, Centre for Experimental Medicine and Rheumatology, William Harvey Research Ins · Pubmed 26034155
2011
  • Division of Immunology and Rheumatology,Stanford University, 1000 Welch Road #203, Palo Alto, CA 94304, USA. · Pubmed 21285160
2010
  • Division of Rheumatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA. · Pubmed 20969557
  • Stanford University, Palo Alto, CA, USA. · Pubmed 20448284
Miscellaneous cities in California
2016
  • Private residence, CA, USA. · Department of Medicine, Karolinska Institute, Stockholm, Sweden. · Department of Internal Medicine, Seoul National University, Seoul, Republic of Korea. · Rheumatology Department, Metroplex Clinical Research Center, Dallas, TX. · Medicines Development Group, Pfizer Inc, Groton, CT and. · Medicines Development Group, Pfizer Inc, New York, NY, USA. · Medicines Development Group, Pfizer Inc, Groton, CT and · Pubmed 26929445
New York University
2015
  • From Division of Immunology/Rheumatology, Stanford University School of Medicine, Stanford, CA; New York University Langone Medical Center, New York, NY; Drexel University College of Medicine, Philadelphia, PA; UCB Pharma, Smyrna, GA, USA; Kennedy Institute of Rheumatology, Oxford, UK.V. Strand, MD, FACP, FACR, Biopharmaceutical Consultant; Adjunct Professor, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.C. Wright, MD, New York University Langone Medical Center; M.J. Bergman, MD, Drexel University College of Medicine; J. Tambiah, MD, UCB Pharma; P.C. Taylor, MD, Kennedy Institute of Rheumatology. · Pubmed 26233504
2009
  • Department of Rheumatology, New York University Hospital for Joint Diseases, New York, NY 10003, USA. · Pubmed 19395544
Miscellaneous institutions in San Francisco Bay area
2015
  • Biopharmaceutical Consultant, Portola Valley, CA, USA. · Stanford University, Palo Alto, CA, USA. · Center for Rheumatology, Albany Medical College, Albany, NY, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Pfizer Inc, 445 Eastern Point Road, MS 8260-2515, Groton, CT, 06340, USA. · Metroplex Clinical Research Center, Dallas, TX, USA. · Pubmed 26530039
  • Medical University of Vienna and Hietzing Hospital, Vienna, Austria. · Department of Medicine, Medical University of Vienna and Hietzing Hospital, Vienna, Austria. · Karolinska Institute, Stockholm, Sweden. · UCSD, San Diego, CA, USA. · Biopharmaceutical Consultant, Portola Valley, CA, USA. · Rheumatology Institute, Prague, Czech Republic. · University of Colorado, Denver, CO, USA. · Academic Medical Centre, Amsterdam, Netherlands. · Centre Hospitalier de l'Université de Montréal, Montreal, Canada. · UCB Pharma, Brussels, Belgium. · UCB Pharma, Brussels, Belgium. · UCB Pharma, Brussels, Belgium. · Leiden University, Leiden, Netherlands. · Pubmed 26353833
  • Biopharmaceutical consultant, Portola Valley, California. · Pubmed 25186034
Drexel University
2015
  • From Division of Immunology/Rheumatology, Stanford University School of Medicine, Stanford, CA; New York University Langone Medical Center, New York, NY; Drexel University College of Medicine, Philadelphia, PA; UCB Pharma, Smyrna, GA, USA; Kennedy Institute of Rheumatology, Oxford, UK.V. Strand, MD, FACP, FACR, Biopharmaceutical Consultant; Adjunct Professor, Division of Immunology/Rheumatology, Stanford University School of Medicine; G.C. Wright, MD, New York University Langone Medical Center; M.J. Bergman, MD, Drexel University College of Medicine; J. Tambiah, MD, UCB Pharma; P.C. Taylor, MD, Kennedy Institute of Rheumatology. · Pubmed 26233504
43 Other Locations Show
Yearly article counts 048764261365
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.